Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 2 Results

Intervention Indication Therapeutic Area Year Actions
Elexacaftor/tezacaftor/ivacaftor (fixed-dose combination) for cystic fibrosis heterozygous for F508del mutation in patients aged 12 years old and older Elexacaftor (VX-445) , Ivacaftor (Kalydeco; VX-770) , Tezacaftor (VX-661) Cystic fibrosis Genetic Disorders , Respiratory System 2020 View  |  Download
Vanzacaftor / tezacaftor / deutivacaftor for the treatment of cystic fibrosis Deutivacaftor , Tezacaftor (VX-661) , Vanzacaftor Cystic fibrosis Genetic Disorders , Respiratory System 2023 View  |  Download
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications